Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Showing posts with label criminal. Show all posts
Showing posts with label criminal. Show all posts
Sunday, September 22, 2013
Fourth Question of the Day, September 22, 2013 Since there appears to be wide spread corruption and lack of ability to police ones on self among the State Board of Pharmacies when it comes to Compounding Pharmacies and Pharmacists Should Congress Consider Tasking the Department of Justice With a Priority of Criminal Investigations into this Area and Provide It With Dedicated Positions to Handle Pharmacy and Prescription Law Crimes in additon to the already mandated Health Care Fraud Positions.
Friday, December 28, 2012
Doctor pleads not guilty to illegal weight-loss meds 2 Bucyrus patients were on the physician's client list
COSHOCTON — Dr. David A. Velasquez, accused of illegally selling weight-loss medication, pleaded not guilty Thursdsay to charges brought by indictment of a recent grand jury.
While he’s lived in the United States as a permanent resident with a green card, Velasquez retains his citizenship with El Salvador, said Jill Del Greco, spokesperson for the Ohio Attorney General’s Office.
Therefore he has the right to notify the El Salvador Embassy of the felony charges against him, according to the Ohio Attorney General’s Office. If Velasquez chooses to notify the embassy of his status, a consular officer has the right to visit him and arrange for legal representation, according to the U.S. State Department.
Continue reading here
Monday, October 1, 2012
Drug giants fined $11bn for criminal wrongdoing; Fines are not enough to reform drug industry, warn lawyers
The Independent has an article entitled Drug Giants Fined $11bn for Criminal Wrongdoing, written by Jeremy Laurance and published September 20, 2012. To read this article click here.
Thursday, August 2, 2012
Another Example of a Federal Prosecution Involving Compounded Drugs
Former Vice-President Of Pharmacutical Company Pleads Guilty To FDA Violations And Health Care Fraud
– Company received more than $2 million in payments from Medicare for misbranded, adulterated and contaminated inhalation medications
February 7, 2012
Johnny Perry, age 62, of Mt. Washington, Kentucky, was indicted by a federal grand jury in Louisville on August 3, 2011. The five count indictment alleged that between June of 2006 and June of 2008, Perry, as vice-president of NRS, provided compounded medications to patients, but led both Medicare and the patients’ doctors to believe that the pharmaceutical company was providing non-compounded medications (FDA approved-commercially manufactured). Compounded medications are not FDA approved, but FDA regulations permit pharmacists to make compounded drugs, including prescription drugs, in limited amounts and under narrow circumstances, for particular patients, and at the direction of a physician when other available drugs cannot be prescribed.
The defendant, through the NRS Corporation submitted false and fraudulent claims to Medicare for the cost of FDA-approved, commercially manufactured, prescription inhalation drugs, when they were not. As a result of this conduct, NRS received approximately $2,030,343 in payments from Medicare to which they were not legally entitled.
It is further alleged that Ms. Perry, aided and abetted by others, from November 2006 through June 2008, misbranded inhalation drugs in that they contained false and misleading labeling that misrepresented the strength and potency of their active ingredients or the type of drug actually provided. During the same period it is alleged that Perry, aided and abetted by others, adulterated inhalation drugs in that the strength differed from what it was purported or represented to possess and that the drugs were contaminated and non-sterile.
“This case should send a clear message that offenses endangering public health will be vigorously prosecuted,” stated U.S. Attorney David J. Hale. “Misrepresenting the strength and potency of a prescribed medication and delivering contaminated products to patients are unconscionable crimes.”
“The Office of Inspector General is committed to protecting the health of patients covered by Medicare and Medicaid,” said Derrick L. Jackson, Special Agent in Charge of the U.S. Department of Health and Human Services in Atlanta, Georgia, “This company billed for medications that never should have been dispensed in the first place which created serious quality of care concerns.”
The maximum potential penalties are 46 years in prison, a $770,000 fine, and supervised release for a period of 3 years.
The case is being prosecuted by Assistant United States Attorney Lettricea Jefferson-Webb and Assistant United States Attorney James Lesousky, and it was investigated by the Food and Drug Administration, Health and Human Services Office of Inspector General, United States Postal Inspection Service, and the Federal Bureau of Investigation.
Press Release Found here.
Monday, July 9, 2012
Doctor Facing Prison For Purchasing Unapproved Cancer Drugs
Doc Saved $790K Using Cancer Drugs Unapproved by FDA - NBC Washington
A Maryland oncologist is facing a year in prison after pleading guilty to introducing a mis-branded drug into interstate commerce.
Dr. Isabella Martire, 52, of Laurel, bought $200,000 worth of drugs not approved by the FDA for use in the U.S. from a England-based wholesaler last year, according to Maryland U.S. Attorney Rod Rosenstein. In 2010 and 2011, Martire treated her cancer patients with the mis-branded drugs and sought reimbursement from Medicare, Medicaid, TRICARE, private health insurers and federal employee health benefit plans.
Martire saved at least $790,600 in 2010 by purchasing the mis-branded drugs, according to the U.S. attorney.
Federal law enforcement investigating the wholesaler for importing drugs approved for use only outside the U.S. searched Martire’s office in May and seized several boxes of mis-branded drugs, including some with labels almost entirely in Turkish, according to the U.S. attorney.
via nbcwashington.com
Subscribe to:
Posts (Atom)